Fig. 2

Representative patient treated with reirradiation, temozolomide, and bevacizumab (ReRT/TMZ/Bev) showing a favorable response (Case 11). A Preoperative T1-weighted magnetic resonance image with gadolinium enhancement and B fluid-attenuated inversion recovery (FLAIR) image showing an enhanced tumor in the left cerebellum (black arrow). C T1-weighted magnetic resonance image with gadolinium enhancement and D FLAIR image obtained 9.8 months after ReRT/TMZ/Bev treatment showing a favorable response (white arrow)